| Summary of disaggregation of revenue from contracts with customers |
The table below shows the disaggregation of the Group’s revenue from contracts with external customers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2021 |
|
(EUR thousand) |
|
Biopharmaceutical and Diagnostic Solutions |
|
|
Engineering |
|
|
Total |
|
Type of goods or service |
|
|
|
|
|
|
|
|
|
Revenues from high-value solutions |
|
|
207,815 |
|
|
|
— |
|
|
|
207,815 |
|
Revenues from other containment and delivery solutions |
|
|
486,223 |
|
|
|
— |
|
|
|
486,223 |
|
Revenues from engineering |
|
|
— |
|
|
|
149,882 |
|
|
|
149,882 |
|
Total revenue from contracts with customers |
|
|
694,038 |
|
|
|
149,882 |
|
|
|
843,920 |
|
|
|
|
|
|
|
|
|
|
|
Geographical markets |
|
|
|
|
|
|
|
|
|
EMEA |
|
|
415,489 |
|
|
|
77,985 |
|
|
|
493,474 |
|
APAC |
|
|
79,463 |
|
|
|
38,284 |
|
|
|
117,747 |
|
North America |
|
|
175,231 |
|
|
|
31,730 |
|
|
|
206,961 |
|
South America |
|
|
23,855 |
|
|
|
1,883 |
|
|
|
25,738 |
|
Total revenue from contracts with customers |
|
|
694,038 |
|
|
|
149,882 |
|
|
|
843,920 |
|
|
|
|
|
|
|
|
|
|
|
Timing of revenue recognition |
|
|
|
|
|
|
|
|
|
Goods and services transferred at a point in time |
|
|
667,717 |
|
|
|
35,477 |
|
|
|
703,194 |
|
Goods and services transferred over time |
|
|
26,321 |
|
|
|
114,405 |
|
|
|
140,726 |
|
Total revenue from contracts with customers |
|
|
694,038 |
|
|
|
149,882 |
|
|
|
843,920 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2020 |
|
(EUR thousand) |
|
Biopharmaceutical and Diagnostic Solutions |
|
|
Engineering |
|
|
Total |
|
Type of goods or service |
|
|
|
|
|
|
|
|
|
Revenues from high-value solutions |
|
|
146,332 |
|
|
|
— |
|
|
|
146,332 |
|
Revenues from other containment and delivery solutions |
|
|
418,599 |
|
|
|
— |
|
|
|
418,599 |
|
Revenues from engineering |
|
|
— |
|
|
|
97,106 |
|
|
|
97,106 |
|
Total revenue from contracts with customers |
|
|
564,931 |
|
|
|
97,106 |
|
|
|
662,037 |
|
|
|
|
|
|
|
|
|
|
|
Geographical markets |
|
|
|
|
|
|
|
|
|
EMEA |
|
|
338,564 |
|
|
|
59,575 |
|
|
|
398,139 |
|
APAC |
|
|
54,433 |
|
|
|
12,702 |
|
|
|
67,135 |
|
North America |
|
|
151,418 |
|
|
|
23,501 |
|
|
|
174,919 |
|
South America |
|
|
20,516 |
|
|
|
1,328 |
|
|
|
21,844 |
|
Total revenue from contracts with customers |
|
|
564,931 |
|
|
|
97,106 |
|
|
|
662,037 |
|
|
|
|
|
|
|
|
|
|
|
Timing of revenue recognition |
|
|
|
|
|
|
|
|
|
Goods and services transferred at a point in time |
|
|
553,789 |
|
|
|
38,417 |
|
|
|
592,207 |
|
Goods and services transferred over time |
|
|
11,142 |
|
|
|
58,689 |
|
|
|
69,830 |
|
Total revenue from contracts with customers |
|
|
564,931 |
|
|
|
97,106 |
|
|
|
662,037 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2019 |
|
(EUR thousand) |
|
Biopharmaceutical and Diagnostic Solutions |
|
|
Engineering |
|
|
Total |
|
Type of goods or service |
|
|
|
|
|
|
|
|
|
Revenues from high-value solutions |
|
|
90,700 |
|
|
|
— |
|
|
|
90,700 |
|
Revenues from other containment and delivery solutions |
|
|
364,341 |
|
|
|
— |
|
|
|
364,341 |
|
Revenues from engineering |
|
|
— |
|
|
|
81,498 |
|
|
|
81,498 |
|
Total revenue from contracts with customers |
|
|
455,041 |
|
|
|
81,498 |
|
|
|
536,539 |
|
|
|
|
|
|
|
|
|
|
|
Geographical markets |
|
|
|
|
|
|
|
|
|
EMEA |
|
|
270,339 |
|
|
|
52,485 |
|
|
|
322,824 |
|
APAC |
|
|
41,129 |
|
|
|
14,393 |
|
|
|
55,522 |
|
North America |
|
|
119,054 |
|
|
|
13,381 |
|
|
|
132,435 |
|
South America |
|
|
24,519 |
|
|
|
1,239 |
|
|
|
25,758 |
|
Total revenue from contracts with customers |
|
|
455,041 |
|
|
|
81,498 |
|
|
|
536,539 |
|
|
|
|
|
|
|
|
|
|
|
Timing of revenue recognition |
|
|
|
|
|
|
|
|
|
Goods and services transferred at a point in time |
|
|
455,041 |
|
|
|
33,684 |
|
|
|
488,725 |
|
Goods and services transferred over time |
|
|
— |
|
|
|
47,814 |
|
|
|
47,814 |
|
Total revenue from contracts with customers |
|
|
455,041 |
|
|
|
81,498 |
|
|
|
536,539 |
|
|